Shelley is a savvy business leader with extensive commercial experience in global healthcare having spent over 20 years at a Fortune 500 company, Merck and Co.
Recognized as an energetic leader and out-of-the-box thinker, Shelley has been successful in driving business results through leadership roles in strategy, marketing, government, and stakeholder engagement and mobilization.
She set precedents in innovative partnerships during her tenure in government access and has had P & L responsibility for multi-million dollar brands. Having accumulated vast therapeutic expertise in Primary Care, Hospital, Specialty and Oncology business, Shelley currently serves as Director on the Board of the Alzheimer’s society.
Shelley holds a Bachelor of Arts in Economics from McGill University and a Master of Science in Administration from Concordia University.